Michelle Franz Montan Braga Leite
Piracicaba, São Paulo, 13414903, Brazil
NCT Number: NCT03855397
A randomized, crossover, double-blind, placebo-controlled, one-session clinical trial with 30 male volunteers was performed to access pain and safety of microneedle topical application in different regions of the oral cavity.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Piracicaba, São Paulo, 13414903, Brazil
A randomized, crossover, double-blind, placebo-controlled, one-session clinical trial with 30 male volunteers was performed by applying a microneedle patch in the following regions of the oral cavity: lip (inner lower), buccal (cheek: 1 cm behind the month angle), tongue (dorsal surface), hard palate (anterior region), and attached gingiva (between central and lateral upper incisors). A 30 gauge hypodermic needle and an identical patch but without microneedles sticking out, were used as positive and negative controls, respectively. The application force was standardized to 10N by an applicator composed of a 5 mL syringe and a spring. Insertions were performed with a gap of 30 seconds. Pain and discomfort associated to the procedure was evaluated with a Visual Analogue Scale (VAS), by a blinded-dentist. The safety associated to microneedle application was verified immediately after the application (0h) and after the next day (24h). The different application sites were inspected visually for bleeding, ulceration, bruising, redness or swelling.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A microneedle patch (no drug) was applied in the following oral cavity sites: lip, buccal, tongue, palatal and gingival mucosa to access pain, discomfort and safety.
30 gauge hypodermic needle was inserted in the following oral cavity sites: lip, buccal, tongue, palatal and gingival mucosa.
Other names: positive control
A flat patch was applied in the following oral cavity sites: lip, buccal, tongue, palatal and gingival mucosa.
Other names: negative control
Time frame: 30 seconds
Pain was evaluated after microneedles, hypodermic needle or negative control topical application application in different oral cavity sites
Time frame: 24 hours
Any sign of ecchymosis, ulceration, redness, swelling or bleeding right after and 24 h later applications of the devices in different oral cavity sites
Time frame: Right after microneedle application
Mucosal perforation after microneedles application was confirmed by applying gentian violet to stain the sites of microneedle insertion
University of Campinas, Brazil
Other
Pain and Safety of Microneedle Application in the Oral Cavity of Human Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05912335
Dental Trauma, Local Anesthesia
Piracicaba, São Paulo, Brazil
View Trial DetailsNCT05267938
Mouth Diseases, Oral Cavity Disease
Piracicaba, São Paulo, Brazil
View Trial DetailsNCT06381505
Mouth Diseases, Oral Cavity Disease
Lebanon, New Hampshire, United States
View Trial DetailsNCT05911750
Communicable Diseases, DNA Virus Infections
Barcelona, Spain
View Trial Details